Aker BP ASA (0M5J)
London Exchange · UK · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 381.30 |
|---|---|
| 52-week range | 241.60 – 386.92 |
| Return, 1 month / 3 months | +9.7% / +14.3% |
| Return, 1 year / 3 years | +62.5% / +59.2% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 33.2% |
| Worst drawdown (1 year) | -17.9% |
| Average daily value traded | 142.39M NOK |
| Dividend yield | 6.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aker BP is an oil and gas company focused on exploration and production on the Norwegian continental shelf. It develops and operates offshore fields that produce crude oil and natural gas, and it also explores for new resources in nearby waters. Its customers are the international energy markets that take delivery of its oil and gas output. The company is headquartered in Norway and works closely with partners and contractors on offshore installations and subsea systems.
On this site Aker BP ASA appears as a stock on the London Exchange (UK), code 0M5J, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aker BP ASA (0M5J) trades on the London Exchange in UK. It last closed at NOK 381.30 on 22 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 36 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 62.5% and over the last three months it rose 14.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.9% | ||
| From 52-week high | -0.4% | ||
| Momentum | 82 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.3% | ||
| 6-month return | 15.2% | ||
| 12-month return, skipping the last month | 48.2% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.9% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 142.39M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.6% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | +9.7% |
| 3 months | +14.3% |
| 6 months | +15.2% |
| 1 year | +62.5% |
| 3 years | +59.2% |
| 5 years | +73.4% |
Signals
| 50-day / 200-day average | 355.32 / 320.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.54 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jul 2026 | NOK 6.4259 |
| 12 May 2026 | NOK 6.1285 |
| 16 Feb 2026 | NOK 6.2942 |
| 27 Oct 2025 | NOK 6.3319 |
| 18 Jul 2025 | NOK 6.3619 |
| 12 May 2025 | NOK 6.5174 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.